Hunan Er Kang Pharmaceutical (300267) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.034x

Based on the latest financial reports, Hunan Er Kang Pharmaceutical (300267) has a cash flow conversion efficiency ratio of 0.034x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥174.55 Million ≈ $25.54 Million USD) by net assets (CN¥5.09 Billion ≈ $745.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Hunan Er Kang Pharmaceutical worth for the company's overall valuation and market capitalisation.

Hunan Er Kang Pharmaceutical - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Hunan Er Kang Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Er Kang Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Er Kang Pharmaceutical ranked by their cash flow conversion efficiency. Explore 300267 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
KCTech Co Ltd KO:281820	-0.008x
Retail Estates - Sicafi BR:RET	0.026x
Quantum Corporation NASDAQ:QMCO	-0.034x
Beijing Asiacom Information Technology Co.Ltd SHE:301085	N/A
GIGAVIS LTD (PROPOSED) KQ:420770	0.000x
Mega Lifesciences Public Company Limited BK:MEGA	0.046x
Pacira BioSciences, Inc. NASDAQ:PCRX	0.086x
ZYNP Corp SHE:002448	0.008x

Annual Cash Flow Conversion Efficiency for Hunan Er Kang Pharmaceutical (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Er Kang Pharmaceutical from 2008 to 2024. View 300267 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.40 Billion ≈ $644.18 Million	CN¥166.69 Million ≈ $24.39 Million	0.038x	+22.71%
2023-12-31	CN¥4.81 Billion ≈ $703.86 Million	CN¥148.42 Million ≈ $21.72 Million	0.031x	-44.54%
2022-12-31	CN¥5.05 Billion ≈ $739.13 Million	CN¥281.02 Million ≈ $41.12 Million	0.056x	+192.56%
2021-12-31	CN¥4.87 Billion ≈ $713.18 Million	CN¥92.68 Million ≈ $13.56 Million	0.019x	-38.29%
2020-12-31	CN¥5.79 Billion ≈ $847.78 Million	CN¥178.53 Million ≈ $26.12 Million	0.031x	-59.96%
2019-12-31	CN¥5.79 Billion ≈ $847.71 Million	CN¥445.82 Million ≈ $65.24 Million	0.077x	+250.28%
2018-12-31	CN¥5.64 Billion ≈ $825.21 Million	CN¥123.89 Million ≈ $18.13 Million	0.022x	-82.75%
2017-12-31	CN¥5.41 Billion ≈ $791.90 Million	CN¥689.11 Million ≈ $100.84 Million	0.127x	+37.27%
2016-12-31	CN¥5.24 Billion ≈ $767.41 Million	CN¥486.50 Million ≈ $71.19 Million	0.093x	-23.90%
2015-12-31	CN¥4.26 Billion ≈ $622.97 Million	CN¥518.96 Million ≈ $75.94 Million	0.122x	+16.62%
2014-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥175.38 Million ≈ $25.66 Million	0.105x	-19.97%
2013-12-31	CN¥1.33 Billion ≈ $195.21 Million	CN¥174.22 Million ≈ $25.49 Million	0.131x	+80.97%
2012-12-31	CN¥1.16 Billion ≈ $170.37 Million	CN¥84.02 Million ≈ $12.30 Million	0.072x	+1.24%
2011-12-31	CN¥1.06 Billion ≈ $155.44 Million	CN¥75.72 Million ≈ $11.08 Million	0.071x	-70.36%
2010-12-31	CN¥176.62 Million ≈ $25.85 Million	CN¥42.47 Million ≈ $6.21 Million	0.240x	+159.86%
2009-12-31	CN¥110.01 Million ≈ $16.10 Million	CN¥10.18 Million ≈ $1.49 Million	0.093x	+2663.24%
2008-12-31	CN¥63.01 Million ≈ $9.22 Million	CN¥211.00K ≈ $30.88K	0.003x	--

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$971.87 Million

CN¥6.64 Billion CNY

Market Cap Rank

#9094 Global

#2249 in China

Share Price

CN¥3.22

Change (1 day)

+0.94%

52-Week Range

CN¥2.88 - CN¥4.84

All Time High

CN¥17.60